Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Hair loss in women may have causes other than hormones.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Current murine models need improvement for better human wound healing research translation.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

A male with aromatase deficiency improved bone health with estradiol treatment.

Most skin changes during pregnancy go away after giving birth.

Metformin taken during pregnancy increases SHBG in newborns but doesn't change other hormone levels in mothers or babies.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Zebrafish helped find new ways to prevent drug-induced hair cell death and potential treatments for hearing loss.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.